PDCD1 and small cell lung carcinoma: 3. The detailed classification of T cells in SCLC also revealed the expression pattern of dysfunction and exhaustion markers (such as PDCD1, CTLA4, HAVCR2, LAG3, TIGIT and LAYN), which may be used as immunotherapeutic targets.